Cargando…
Emerging and Established Histological Techniques for the Analysis of Thrombosis in COVID-19 Lungs
Coronavirus disease 2019 (COVID-19) is the potentially lethal disease that is caused by severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2). Patients with COVID-19 have an increased risk of thrombosis, but the role of thrombosis in the pathogenesis and progression of severe COVID-19 remains...
Autores principales: | Spier, Addie B., Evans, Colin E. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8490625/ https://www.ncbi.nlm.nih.gov/pubmed/34621804 http://dx.doi.org/10.3389/fcvm.2021.745906 |
Ejemplares similares
-
Surviving and thriving in thrombosis research during a global pandemic: Experiences of a vascular scientist diagnosed with COVID-19
por: Spier, Addie B., et al.
Publicado: (2021) -
Editorial: Highlights in Thrombosis: 2021
por: Evans, Colin E.
Publicado: (2022) -
The cross-talk of lung and heart complications in COVID-19: Endothelial cells dysfunction, thrombosis, and treatment
por: Liu, Langjiao, et al.
Publicado: (2022) -
Novel therapeutics and emerging technology in haemostasis and thrombosis: highlights from the British society for haemostasis and thrombosis annual meeting
por: Whyte, Claire S., et al.
Publicado: (2023) -
Cumulative Evidence for the Association of Thrombosis and the Prognosis of COVID-19: Systematic Review and Meta-Analysis
por: Xiao, Dongqiong, et al.
Publicado: (2022)